ICTD 2019: Patient Stratification Studies, Paris, 20 May
ECRIN and its French scientific partner, the French Clinical Research Infrastructure Network (F-CRIN), organised a conference in Paris, France on May 20th, 2019 to celebrate International Clinical Trials Day (ICTD).
ICTD 2019 brought together ECRIN’s internal stakeholders and partners, and additional scientists and policymakers from France, the rest of Europe, and beyond. The meeting objective was to engage participants in discussion on issues related to multinational clinical trials and the clinical research landscape in Europe. ICTD 2019 focussed on challenges raised by patient stratification studies.
The meeting took place at Luxembourg Palace, 15 rue de Vaugirard, 75006 Paris from 10:30 to 16:30 CET.
Click here to download the agenda
Click here to read the press release
(in English, with a French version available for download)
Speaker topics & presentations
- Introduction to ICTD 2019: Jacques Demotes, director general, ECRIN (Paris, France)
- The ‘AETIONOMY’ study: Jean-Christophe Corvol, professor of neurology (ICM, Pitié-Salpêtrière Hospital, APHP, Inserm, Sorbonne Université) (Paris, France)
- Design and statistical methodology in patient stratification programmes: stratification cohort, validation cohort, clinical trials: Raphaël Porcher, associate professor of biostatistics at Paris Descartes University (Paris, France)
- Multimodal data management: clinical, multi-omics and imaging data: Jan-Willem Boiten, programme manager at Lygature (Utrecht, Netherlands)
- Machine learning algorithms for patient stratification: David Sadek, vice president for Research, Technology & Innovation, Thales (Paris, France)
- Multinational cohort integration: Josep Maria Haro, research and teaching director of Fundació Sant Joan de Déu (Barcelona, Spain)
- Reuse of data and biosamples, informed consent and personal data protection challenges: Michaela Th. Mayrhofer, chief policy officer, head of CS ELSI, BBMRI-ERIC (Graz, Austria)
- Promoting international cooperation in personalised medicine research: International Consortium for Personalised Medicine (ICPerMed): Astrid Vicente, senior researcher, head of the Department of Health Promotion and Non-communicable Disease Prevention, Instituto Nacional de Saúde Doutor Ricardo Jorge (Lisbon, Portugal); ICPerMed vice-chair
- The challenges of patient stratification studies and personalised treatments for health technology assessment: Frank Hulstaert, senior researcher, Belgian Health Care Knowledge Centre (KCE) (Brussels, Belgium)
Photo gallery
©Annie Gozard 2019
Pictured, from left to right: Olivier Rascol (Coordinator, F-CRIN), Jacques Demotes (Director General, ECRIN), Gérard Larcher (President of the Senate), Gilles Bloch (CEO of Inserm), Vincent Diebolt (Executive Director, F-CRIN).
